Bernd Dörken

Charité - Universitätsmedizin Berlin — Germany

Medicine · Health Sciences

98h-index33.7kcitations629works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(91), Lymphoma Diagnosis and Treatment(88), Acute Myeloid Leukemia Research(76), Chronic Myeloid Leukemia Treatments(75), CAR-T cell therapy research(73)

Publications628 total

Table S1 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Supplementary Movie 1 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Supplemental Figures S1-S3 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Data from A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells <i>In Vivo</i>
2023Open Access
Supplementary Movie 1 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Data from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Supplemental Figures S1-S5 from A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells <i>In Vivo</i>
2023Open Access
Supplemental figure and table legends from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Supplementary Methods, Figures S1 - S9 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Supplementary Movie 2 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Table S2 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Supplementary Methods, Figures S1 - S9 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Data from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Data from A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells <i>In Vivo</i>
2023Open Access
Table S2 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Data from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Supplemental Figures S1-S3 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
Supplementary Movie 2 from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Data from Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
2023Open Access
Table S1 from CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
2023Open Access
page 1 of 32Next →

Frequent Co-authors

Stephan Mathas(8), Harald Stein(7), Michael Hummel(7), Volker Diehl(7), Ioannis Anagnostopoulos(7), Andreas Engert(6), Ralf C. Bargou(6), Daniel Krappmann(6), Hanno Riess(6), Clemens A. Schmitt(5), Kurt Bommert(5), Markus Y. Mapara(5), Claus Scheidereit(5), Uwe Pelzer(5), Franziska Jundt(5), Martin Janz(5), Georg Lenz(5), Thomas Wieder(5), Peter T. Daniel(5), Soyoung Lee(4)